Sheng-Nan Zheng

SARS‐CoV‐2 NSP8 suppresses type I and III IFN responses by modulating the RIG‐I/MDA5, TRIF, and STING signaling pathways

Peihui Wang, Chengjiang Gao, Yi Zheng, 2023, Journal of medical virology.

SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathways

Jia-Yu Pan, Peihui Wang, Chengjiang Gao, 2023, Journal of medical virology.